Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05730556 · ClinicalTrials.gov registry record · NA
A Study of Remote Electrical Neuromodulation for Acute Procedural Pain
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05730556: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT05730556 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05730556, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effectiveness of using remote electrical neuromodulation, using the Nerivio ® device, to relieve pain associated with receiving onabotulinumtoxinA (Botox) injections for chronic migraine prevention.
Interventions
- DEVICE Sham
- DEVICE Nerivio ®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-02-13 |
| Est. Completion | 2024-09-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05730556
The ClinicalTrials.gov registry entry for NCT05730556 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT05730556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05730556 about?
NCT05730556 is a clinical study titled "A Study of Remote Electrical Neuromodulation for Acute Procedural Pain". The purpose of this study is to assess the effectiveness of using remote electrical neuromodulation, using the Nerivio ® device, to relieve pain associated with receiving onabotulinumtoxinA (Botox) injections for chronic migraine prevention.
What is the current status of trial NCT05730556?
This trial is currently terminated. It is a NA study. The enrollment target is 80 participants. The study started on 2023-02-13. Estimated completion is 2024-09-09.
What interventions are being tested in trial NCT05730556?
The interventions under investigation include: Sham (DEVICE), Nerivio ® (DEVICE).
Who is sponsoring clinical trial NCT05730556?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.